Copyright © 2001 by the European Society of Cardiology.
Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study
a Karolinska Hospital, Stockholm, Sweden
b University of Minnesota, Minneapolis, Minnesota, U.S.A.
c Mid America Heart Institute, Kansas City, Missouri, U.S.A.
d Medtronic Incorporated, Minneapolis, Minnesota, U.S.A.
revised August 20, 2000; accepted August 23, 2000
Abstract
Background Implantable sensors that monitor haemodynamics over time may be useful in patients with heart failure. This multicentre study assessed the feasibility of a system that has one sensor measuring absolute pressure and another measuring mixed venous oxygen saturation (SvO2). Both sensors were mounted on leads that were implanted in the right ventricle.
Methods Twenty-one patients with heart failure (NYHA II-III) were included. Comparisons were made to right heart catheterizations at implant and at 2, 6 and 12 months thereafter. Patients underwent several haemodynamic provocations during the catheterizations.
Results Overall, among functioning sensors, the IHM-1 values were highly correlated with reference values for all time points during all provocations, demonstrating high reproducibility and stability (r2=0¶91, 0¶79 and 0¶78 for systolic, right ventricular diastolic and SvO2, respectively). Although IHM-1 underestimated reference pressure values by 4¶5mmHg and SvO2by 1¶6%, this difference was consistent across provocation and stable over 12 months of follow-up. Twelve of the 21 oxygen sensors failed to function and two pressure sensors had component failures. Preliminary analysis of long-term data revealed haemodynamic patterns that may be key indicators for therapeutic interventions.
Conclusion This multicentre feasibility study demonstrated the accuracy and stability of sensors implanted in the right ventricle. The IHM-1, using right ventricular pressures and SvO2, with improved performance, might be useful in the study of pathophysiological mechanisms and treatment interventions in heart failure.
Key Words: Heart failure, haemodynamics, ventricles, pressure oxygen
f1 Correspondence: Lars Rydén, MD, FESC, Department of Cardiology, Karolinska Hospital, 171 76 Stockholm, Sweden.
References
- Franciosa JA, Dunkman WB, Leddy CL. Hemodynamic effects of vasodilators and long-term response in heart failure. J Am Coll Cardiol. 1984;3:15211530[Abstract]
- Packer M. Vasodilator and innotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope. J Am Coll Cardiol. 1988;12:12991317[Abstract]
- Stevenson LW, Dracup KA, Tillish JH. Effect of medical therapy for severe congestive heart failure in patients referred for urgent cardiac transplantation. Am J Cardiol. 1989;63:461464[CrossRef][ISI][Medline]
- Fonarow GC, Chelinsky-Fallick C, Stevenson LW. Effect of direct vasodilator with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C Trial. J Am Coll Cardiol. 1992;19:842850[Abstract]
- Ohlsson A, Nordlander R, Bennett T. Continuous ambulatory hemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur Heart J. 1998;19:174184
[Abstract/Free Full Text] - Ohlsson A, Bennett T, Ottenhoff F. Long term recording of cardiac output via an implantable hemodynamic monitoring device. Eur Heart J. 1996;17:19021910
[Abstract/Free Full Text] - Steinhaus DM, Lemery R, Brenahan DR. Initial experience with an implantable hemodynamic monitor. Circulation. 1996;93:745752
[Abstract/Free Full Text] - Faerestrand S, Ohm O, Strangeland L, Heynen H, Moore A. Long-term clinical performance of a central venous oxygen saturation sensor for rate adaptive cardiac pacing. PACE. 1994;17:13551372
- Bennett T, Sharma A, Sutton R, Lamm AJ, Ericksson M, Beck R. Development of a rate adaptive pacemaker based on the maximum rate of rise of right ventricular pressure (RV dP/dtmax). PACE. 1992;15:219234
- Reynolds D, Bartlett N, Taepke R, Bennett T. Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol. 1995;25:11761182[Abstract]
- Ohlsson A, Bennett T, Nordlander R, Rydén J,
strom H, Rydén L. Monitoring of pulmonary arterial diastolic pressure through a right ventricular pressure transducer. J Cardiac Failure. 1995;1:161168[CrossRef][Medline]
- Chuang P, Wilson RF, Homans DC. Measurement of pulmonary artery diastolic pressure from a right ventricular pressure transducer in patients with heart failure. J Cardiac Failure. 1996;2:4146[CrossRef][Medline]
- Ohlsson A, Beck R, Bennett T. Monitoring of mixed venous oxygen saturation and pressure from biosensors in the right ventricle. Eur Heart J. 1995;16:12151222
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
R. C. Bourge, W. T. Abraham, P. B. Adamson, M. F. Aaron, J. M. Aranda Jr, A. Magalski, M. R. Zile, A. L. Smith, F. W. Smart, M. A. O'Shaughnessy, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1073 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Page, S. Cazeau, P. Ritter, D. Galley, and C. Casset Physiological approach to monitor patients in congestive heart failure: application of a new implantable device-based system to monitor daily life activity and ventilation Europace, August 1, 2007; 9(8): 687 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zima, M. Lippert, G. Czygan, and B. Merkely Determination of left ventricular volume changes by intracardiac conductance using a biventricular electrode configuration Europace, July 1, 2006; 8(7): 537 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Wadas The Implantable Hemodynamic Monitoring System Crit. Care Nurse, October 1, 2005; 25(5): 14 - 26. [Full Text] [PDF] |
||||
![]() |
F. M. Fruhwald, B. Kjellstrom, W. Perthold, N. Watzinger, R. Maier, P. A. Grandjean, and W. Klein Continuous Hemodynamic Monitoring in Pulmonary Hypertensive Patients Treated With Inhaled Iloprost Chest, July 1, 2003; 124(1): 351 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.A. Poole-Wilson Importance of control of fluid volumes in heart failure Eur. Heart J., June 1, 2001; 22(11): 893 - 894. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




